, Japan

Unbranded channels lead digital breast cancer patient engagement

Such websites aim to heighten awareness on managing the disease.

Digital patient engagement through unbranded channels has been more prominent in Japan's breast cancer treatment landscape, according to a report from GlobalData.

The breast cancer market size in Japan is estimated to grow from $1.63b in 2020 to $2.06b in 2025, at a compound annual growth rate (CAGR) of 24.9%, driven by rising incidences of the disease and innovation in treatment.

As early diagnosis plays an important role in controlling the progression of the disease, key players have been offering branded websites to explain treatment benefits and provide access to the drug, commented GlobalData's pharma analyst Venkat Katheek Vale.

Unbranded websites are aiming to create awareness of the disease and the disease management, which encourages patients to start treatment for their condition, Vale added.

Furthermore, the portfolio of unbranded websites developed by Roche / Chugai Pharmaceutical and Pfizer showed that patient engagement through their unbranded websites will help expand the patient base.

“Since the leading therapies such as Avastin and Herceptin are facing biosimilar competition and the overall market size is expected to decrease in terms of value, key players are focusing on promoting innovative therapies,” Vale said.

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Get Health Care Asia Magazine in your inbox

Find out who won at this year's Healthcare Asia Awards and Healthcare Asia Pharma Awards 

The event was held via video conferencing that started last 15 April.

What investment opportunities await for India’s health-tech space?

Before the pandemic, the industry focussed on wearables, lifestyle-linked problems, and more.

Singapore’s Tan Tock Seng Hospital closes wards to visitors

Two patients and two staff were infected by COVID-19.

Hygeia Healthcare buys 100% stake in Etern Group for $268m

The acquisition indirectly holds 98% of Suzhou Yongding Hospital in Jiangsu.

How reach52 bridges the gap in healthcare with tech

The unique startup aims to connect to 250 million individuals across the globe by 2030.

He Health bags internet hospital license in China

The online platform offers services such as men’s health consultations.

Indonesia's telehealth platform Halodoc bags $80m in funding

The funds will be used to deepen its penetration in key healthcare verticals in Indonesia.

South Korea eases requirements for drug imports

Pharmaceutical companies could benefit from the government’s drive to reduce regulatory uncertainty.

Taiwan's novel pharma products hit by low reimbursement prices

The low rates are discouraging the launch of new innovative products, insiders say.

Japan's liver cancer surveillance program hailed as world's best

The country established the programme for early detection of HCC in the 1980s.